Skip to main content Back to Top
Advertisement

3/26/2020

Daptomycin Injection

Products Affected - Description

    • Daptomycin powder for solution for injection, Pfizer, 500 mg, vial, 1 count, NDC 00409-0106-01 - discontinued

Reason for the Shortage

    • BE Pharmaceuticals has daptomycin available.
    • Dr. Reddy's has daptomycin available.
    • Fresenius Kabi has daptomycin available.
    • Mylan Institutional has daptomycin available.
    • Pfizer discontinued daptomycin in December 2019.
    • Teva has daptomycin available.
    • Sagent had daptomycin on shortage due to manufacturing delays.
    • Merck has Cubicin and Cubicin RF available.
    • Xellia Pharmaceuticals has daptomycin available.

Available Products

    • Cubicin powder for solution for injection, Merck, 500 mg, vial, 1 count, NDC 67919-0011-01
    • Cubicin RF powder for solution for injection, Merck, 500 mg, vial, 1 count, NDC 67919-0012-01
    • Daptomycin powder for solution for injection, BE Pharmaceuticals, 500 mg, vial, 1 count, NDC 71839-0107-01
    • Daptomycin powder for solution for injection, Dr. Reddy's, 500 mg, vial, 1 count, NDC 43598-0413-11
    • Daptomycin powder for solution for injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0371-10
    • Daptomycin powder for solution for injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0871-15
    • Daptomycin powder for solution for injection, Mylan Institutional, 500 mg, vial, 1 count, NDC 67457-0813-50
    • Daptomycin powder for solution for injection, Sagent, 350 mg, vial, 1 count, NDC 25021-0179-15
    • Daptomycin powder for solution for injection, Sagent, 350 mg, vial, 10 count, NDC 25021-0179-16
    • Daptomycin powder for solution for injection, Teva, 500 mg, vial, 1 count, NDC 00703-0125-01
    • Daptomycin powder for solution for injection, Xellia Pharmaceuticals, 350 mg, vial, 1 count, NDC 70594-0053-01
    • Daptomycin powder for solution for injection, Xellia Pharmaceuticals, 500 mg, vial, 1 count, NDC 70594-0034-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated March 26, 2020 by Anthony Trovato, PharmD, BCPS. Created September 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.